This message contains images. If you don't see images, click here to view.
Advertise in this news brief.

Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    



Histotechnology Professionals Day — March 10 — #histoday
Our annual celebration of Histotechnology professionals is less than one month away! We are so excited to recognize all of the hard work you do each and every day. Take a look on the NSH website for upcoming contests and order Histotechnology Professionals Day items for your lab today. This year we have a new beautiful stain available to order on t-shirts, water bottles and a candy bar! We also have other fun items including coasters, badge holders and more. Order online or mail in this form!
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Can mobile health streamline the clinical trial workflow?
HIT Consultant
While we tap away on our mobile devices, the health care industry continues to hone in on the untapped potential of connecting to the millions of users that hold them. The latest area calling for a mobile movement: clinical trials. The growing consensus: the time to clean up the clinical trial work flow has come — and mobile-driven solutions are the tools to get it done.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

  GBI Cost Effective Products

GBI Labs produces the largest selection of secondary detection kits, from single to multiple detection kits, with wide range host species. We provide FREE samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market with 20%-30% cost less.

Fraudulent clinical trials known to FDA 'hidden from journals and public'
Medical News Today
A trawl of internal documents held by the U.S. Food and Drug Administration has revealed official action due to "significant departures from good clinical practice" against a total of 57 clinical trials, including 22 affected by "falsification" — yet a parallel search of the published study reports finds no mention of these grave concerns being made public.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Miss an issue of Under The Microscope? Click here to visit the Under The Microscope archive page.

How lab animal health standards are evolving
Genetic Engineering & Biotechnology News
Health standards have always played a critical role in the use of research lab animals. Evolving industry needs and advancements in research and the animals that support it have made health standards a more prominent consideration. The complexity of biomedical research and the sophistication of animal models make selecting and maintaining models at the right health standard essential.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Partnership of Illumina and bioMérieux proposes epidemiology service to provide hospitals and public health officials 'out-of-the-box' genomic pathogen solutions
Dark Daily
A partnership of San Diego-based genome sequencing company Illumina, and the French multinational, in vitro diagnostics company bioMérieux, plans to launch a next-generation sequencing epidemiology service that will allow microbiologists to rapidly identify strains that threaten hospital inpatients and public health, according to a press release distributed by the Illumina-bioMérieux team.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


'Virtual' recruitment roundtable: Best practices for clinical trial engagement, retention
Clinical Leader
When it comes to patient enrollment and retention, engagement is key. However, keeping a clinical trial moving forward smoothly and keeping patients happy is a daunting, but necessary task. Clinical Leader's recruit experts provide some best practices that can be used to ensure prospective and enrolled patients and their caregivers remain informed and active participants in the clinical trial space.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

AutoSection® - Microtome with a Brian

Conserve tissue and provides reproducible sections for advanced staining

  • Automatically aligns blocks to the blade in seconds
  • Reduces QC rejected slides through precision sectioning
  • Saves wrists and shoulders from unnecessary pain caused by repetitive motion
  • Click here to see all AutoSection has to offer

    For more information call Sakura 800-725-8723
  • Hassle Free Block Storage Cabinet

    Avantik Biogroup is proud to introduce another Customer Requested Quality Innovation for Histology...the Avantik Biogroup Block Storage Cabinet! We introduced Hassle-Free Drawer Technology with Interlocking Stackability and More Clearance between the top of the blocks and the drawers to achieve the industry's first Jam-Free, Hassle-Free Block Storage Cabinet!
    Baptist Health School of Histotechnology

    The Baptist Health School of Histotechnology has an one-year online program that may be the program for you! A non-residential student must have access to an accredited Histology lab and completed 1080 hours of Histology lab experience prior to starting the program. Classes begin in July each year, so call today!

    'Top 10 Clinical Trial Failures of 2014'
    Genetic Engineering & Biotechnology News
    Biopharmas spend millions, or billions, to develop new drugs, yet the consequences of failure in mid- to late-stage clinical trials can go beyond the R&D budget. Numerous aftermaths of trial failure can be seen in this year's "Top 10 Clinical Trial Failures of 2014." Six of the 10 saw immediate pushback from investors, in the form of sharp one-day declines in their stock per-share prices. Three of the 10 saw a halt to development in the indication that touched off a trial failure. One saw its entire clinical development program halted, resulting in its developer taking a charge against earnings. And for two candidates on this year's list, trial failures sparked company restructurings that included elimination of jobs.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Human 'Organs-on-Chips' as replacements for animal testing
    By Jessica Taylor
    Wyss Institutes Founding Director Donald E. Ingber, M.D., Ph.D., kicked off SLAS2015 by focusing on the engineering of human "Organs-on-Chips" to a filled room of SLAS attendees Feb. 9. Researchers, along with Ingber, have created this innovative technology. Organs-on-a-Chip is a cell culture device — crystal clear with flexible polymers and the size of a computer memory stick — that contains hollow channels lined by living cells, and tissues that imitate human cellular response far more effectively and realistically than Petri dish cultures.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Egypt researchers claim to treat cancer with gold
    World Bulletin
    An Egyptian research team has announced the success of animal testing for an experimental cancer treatment that uses gold nanoparticles. They said that all the animals treated with the nanoparticles had recovered from cancer in its early stages.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Clinical trials need a multilateral effort
    Minnesota Daily
    For many years, medical advancements have faced myriad of moral dilemmas. Perhaps one of the most important ones is the ethicality of human trials — not that they happen at all, but rather how they happen, who the subjects are and whether they're in accordance with an appropriate timeline. Recently, a large clinical study testing new HIV-prevention methods throughout Africa failed.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Missed last week's issue? See which articles your colleagues read most.

        Smartphone HIV test tracks disease on the go in research trial (Bloomberg)
    Bacteria may help battle cancer, study suggests (
    Why too many clinical trials fail — and a simple solution that could increase returns on pharma R&D (Forbes)
    Chimerix withdrawing from Ebola clinical trials (News & Observer)
    Scientists find new target for most aggressive breast cancer (Medical News Today)

    Don't be left behind. Click here to see what else you missed.

    Under the Microscope
    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Ashley Whipple, Senior Content Editor, 469.420.2642   
    Contribute news

    This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
    Recent issues
    Feb 10, 2015 Blast
    Feb. 4, 2015
    January 30, 2014 Blast
    Jan 29, 2015 Blast

    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063